Inhibition of HDAC6, known to be upregulated in the lungs and distal pulmonary arteries of PAH patients, was seen to reduce PASMC proliferation as well as sensitize PAH vascular cells to apoptosis through activation of the Ku70 subunit of the DNA-PK complex [67]. Here, HDAC6 is linked to pulmonary arterial hypertension.